Brightsurf Science News & Current Events

October 31, 2001
Yale researchers develop first vaccine for West Nile virus tested successfully in animal model of the disease
Yale scientists have successfully immunized mice against West Nile virus, raising the possibility of developing a vaccine for humans against the potentially fatal, mosquito-borne infection.

Organic Letters' impact factor speaks volumes
Organic Letters, a peer-reviewed journal of the American Chemical Society, the world's largest scientific society, is one of the top 10 journals in organic chemistry, according to the 2000 Institute for Scientific Information Journal Citation Reports.

Old drug shows promise for helping treat advanced lung cancer
Combining standard chemotherapy treatment with a drug once used to treat parasitic infections may give new hope to patients with lung cancer.

Tourette's, other tic disorders far more common than once thought
One out of four students in special-education classes has a tic-related disorder like Tourette syndrome, and the rate of Tourette's among students in the general population is 50 to 75 times higher than has been traditionally thought by doctors, according to physicians who say that the disorder is actually quite common, usually with mild symptoms.

DDR2 and hepatic fibrosis
Deposition of interstial collagen in abnormal locations, the hallmark of fibrosis, can occur in many organs in response to physical trauma or other kinds of insults.

Yale and University of Chicago researchers discover 40-foot crocodile fossil, possibly the largest known so far
The bones of a 40-foot crocodile that dined on dinosaurs and 12-foot-long fish have been discovered by researchers at Yale and at the University of Chicago in the Cretaceous rocks in Niger, Africa.

Dentists deliver preventive messages to finance committee
High Tuition Fees and First Nations Oral Health Key Focuses of Canadian Dental Association Pre-budget brief to Finance Committee

Duke surgeon: use of common clotting agent should be restricted
A substance derived from cow blood and used to control bleeding in more than 500,000 surgeries each year appears to stimulate an abnormal immune response that puts patients at greater risk of suffering from complications, especially if that agent is used in subsequent operations, according to Duke University Medical Center investigators.

World's largest scientific society seeks minority students for scholarship program
The American Chemical Society today announced it has begun accepting applications for its 2002 Minority Scholars Program.

Final Phase I results reported on new cancer drug
Researchers at the Ireland Cancer Center at University Hospitals of Cleveland report promising results of Phase I studies of a new cancer drug (Combretastatin A4P) that destroys the blood vessels supporting tumor growth.

Wealth of new species discovered from the abyssal plains of the Atlantic Ocean
Preliminary findings from an expedition last year to the deep-sea of the Angola Basin are revealing a wealth of new information on biodiversity in the poorly known depths of the south Atlantic Ocean.

Highly specific biological agents attack mechanisms of treatment resistance
A growing field of cancer research is focusing on identifying what confers resistance on cells, so that those survival mechanisms can be targeted and shut down.

OSU scientists study soy and tomato diet in prostate cancer
Scientists at The Ohio State University Comprehensive Cancer Center are studying the effects of adding soy and tomatoes to the diets of men who have prostate cancer, to see if the supplements will slow disease progression.

HMO gatekeeping does not appear to cut specialty visits
Patients will not necessarily visit specialists more often if their HMOs no longer require referrals by a primary care physician, according to a report in the November 1 New England Journal of Medicine.

Sandia-developed formulation among products selected to help rid U.S. facilities of anthrax
Federal authorities are using a decontamination formulation developed at the National Nuclear Security Administration's (NNSA) Sandia National Laboratories to help rid Capitol Hill buildings of anthrax this week.

First global-scale assessment of biodiversity beneath our feet
As part of the Global Litter Invertebrate Decomposition Experiment (GLIDE), last August and September the researchers placed mesh bags of leaf litter on the ground of diverse ecosystems, from tropical to boreal forests, and from to savannahs to arctic tundra.

Study: King Midas' feast offered golden opportunity for fungi
The food buried with King Midas around 700 B.C., along with the king himself, may have fueled a feast for a generally benign type of fungus that led to extensive deterioration of the king's tomb, a new study shows.

GammaDelta T cells in innate anti-bacterial defenses
Innate immune responses, by definition, exist prior to infection and do not involve immunological memory.

Patented technique binds and removes mercury from combustion exhausts
An environmental engineering science professor at Washington University in St.

Prayer, noetic studies feasible; results indicate benefit to heart patients
Cardiac patients who received intercessory prayer in addition to coronary stenting appeared to have better clinical outcomes than those treated with standard stenting therapy alone, according to researchers at Duke University Medical Center.

Chemical society convenes regional meeting in Santa Barbara, October 28-31
Almost 200 research findings are scheduled for presentation at the 37th Western regional meeting of the American Chemical Society, the world's largest scientific society, in Santa Barbara, October 28-31.

Studying growth, poverty and well-being in Africa
To conduct research and training on issues related to promoting economic growth and relieving poverty in Africa, researchers at Cornell University are embarking on an $8 million U.S.

Jefferson researchers show angiostatin and radiation are safe in early trials for advanced cancer
Results from early clinical studies of the highly-publicized cancer drug Angiostatin, designed to halt tumor growth by cutting off its blood supply indicates the medication is safe when combined with radiation therapy in the treatment of advanced cancers.

Sandia modelers help micromachine designers succeed in economic jungle
Just as a movie theater's

Heroin users released from methadone detox or jail may be at higher risk for overdose, according to UCSF researchers
Drug users who inject heroin after completing 21-day methadone programs or after release from jail or prison may have a high risk of overdose, according to UCSF researchers.

Scientists identify cells necessary for tumor angiogenesis
While it has been known that tumors recruit cells to form new blood vessels, and that growth factors are necessary to promote this, the origin of the cells that form the early, new blood vessels has been poorly understood.

Yale-Griffin Prevention Research Center to study complementary care of asthma
The Yale-Griffin Prevention Research Center, part of the Yale School of Medicine, will soon begin work on a study of complementary care for mild to moderate asthma.

NHLBI study finds high-normal blood pressure increases cardiovascular risk
High-normal blood pressure significantly increases the risk of heart attack, stroke, and heart failure, according to a new study supported by the National Heart, Lung, and Blood Institute (NHLBI).

Foxo1 and the insulin resistance of cultured kidney cells
As a normal aspect of energy metabolism, cells in the kidney, much like those in the liver, respond to insulin by suppressing the metabolic pathways by which glucose is generated and released.

Yale researchers develop first microarray chip for complete analysis of proteins
Yale University researcher Michael Snyder and his colleagues have created the first microchip able to analyze virtually all yeast proteins, the chemicals that carry out the activities necessary for life.

Harmless virus prevents HIV variant from spreading in human tissue blocks
Human herpesvirus 6 (HHV-6), a common virus that is apparently harmless in adults, appears to prevent a form of the AIDS virus from reproducing in laboratory cultures of human tissue, according to a study published in the November issue of Nature Medicine.

Meetings launch international program to protect food security and conserve biodiversity
Across the world local networks of researchers, development workers and farmers are joining forces in October and November 2001 to launch an innovative project to protect food security and incomes of the world's rural poor, and at the same time, help conserve biodiversity.

Blood transfusions drastically reduce death in anemic elderly heart attack patients
Yale researchers have found that giving blood transfusions to anemic elderly heart attack patients significantly improves the survival rate for that group.

OSU scientists study novel treatment for leukemia
Scientists at The Ohio State University Comprehensive Cancer Center are studying a new biologic therapy that offers hope to acute leukemia patients who have not responded to chemotherapy.

Estrogen therapy does not reduce risk of recurrent stroke or death, Yale researchers find in WEST Study
Despite many observational studies linking hormone replacement therapy (HRT) to reduced risk of cardiovascular disease and possibly stroke, Yale researchers have found in a new study that HRT does not reduce the risk of a second stroke or death in women with cerebrovascular disease.

American Stroke Association's 27th International Stroke Conference
You are invited to cover the American Stroke Association's 27th International Stroke Conference to be held Feb.

Prevention Research Center to study benefits of home-based exercise in heart failure
he Yale-Griffin Prevention Research Center, part of the Yale School of Medicine, has been awarded a two-year, nearly $200,000 grant from the Centers for Disease Control & Prevention to investigate the benefits of a home-based exercise program for patients with Congestive Heart Failure (CHF).

Majority of pediatric cancer patients use alternative therapies: Fred Hutchinson Cancer Research Center survey
Nearly three-quarters of pediatric cancer patients in western Washington use alternative therapies to treat the cancer or cope with side effects from standard medical treatments.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.